Cargando…

3-Hydroxyphthalic Anhydride-Modified Chicken Ovalbumin as a Potential Candidate Inhibits SARS-CoV-2 Infection by Disrupting the Interaction of Spike Protein With Host ACE2 Receptor

The global spread of the novel coronavirus SARS-CoV-2 urgently requires discovery of effective therapeutics for the treatment of COVID-19. The spike (S) protein of SARS-CoV-2 plays a key role in receptor recognition, virus-cell membrane fusion and virus entry. Our previous studies have reported that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Taizhen, Qiu, Jiayin, Niu, Xiaoge, Ma, Qinhai, Zhou, Chenliang, Chen, Pei, Zhang, Qiao, Chen, Meiyun, Yang, Zifeng, Liu, Shuwen, Li, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840605/ https://www.ncbi.nlm.nih.gov/pubmed/33519467 http://dx.doi.org/10.3389/fphar.2020.603830

Ejemplares similares

3-Hydroxyphthalic Anhydride- Modified Rabbit Anti-PAP IgG as a Potential Bifunctional HIV-1 Entry Inhibitor
por: Zhang, Xuanxuan, et al.
Publicado: (2018)

The Underlying Mechanism of 3-Hydroxyphthalic Anhydride-Modified Bovine Beta-Lactoglobulin to Block Human Papillomavirus Entry Into the Host Cell
por: Hua, Chen, et al.
Publicado: (2019)

Maleic anhydride-modified chicken ovalbumin as an effective and inexpensive anti-HIV microbicide candidate for prevention of HIV sexual transmission
por: Li, Lin, et al.
Publicado: (2010)

α-Linolenic Acid Screened by Molecular Docking Attenuates Inflammation by Regulating Th1/Th2 Imbalance in Ovalbumin-Induced Mice of Allergic Rhinitis
por: Ren, Mengyue, et al.
Publicado: (2022)

CPI‐203 improves the efficacy of anti‐PD‐1 therapy by inhibiting the induced PD‐L1 overexpression in liver cancer
por: Niu, Xiaoge, et al.
Publicado: (2021)

Chicken Egg Yolk Antibodies (IgYs) block the binding of multiple SARS-CoV-2 spike protein variants to human ACE2
por: Wei, Shuangshi, et al.
Publicado: (2021)

Spike residue 403 affects binding of coronavirus spikes to human ACE2
por: Zech, Fabian, et al.
Publicado: (2021)

Landscape of SARS-CoV-2 spike protein-interacting cells in human tissues
por: Zheng, Bingfeng, et al.
Publicado: (2021)

Nascent chicken ovalbumin contains the functional equivalent of a signal sequence
Publicado: (1978)

Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike–ACE2 Interaction
por: Guimond, Scott E., et al.
Publicado: (2022)

Repurposing of a clinically used anti-HPV agent to prevent and treat SARS-CoV-2 infection as an intranasal formulation
por: Hua, Chen, et al.
Publicado: (2021)

Computational studies evidenced the potential of steroidal lactone to disrupt surface interaction of SARS-CoV-2 spike protein and hACE2
por: Yadav, Ajay, et al.
Publicado: (2022)

Desensitization of ovalbumin-sensitized mice by repeated co-administrations of di-(2-ethylhexyl) phthalate and ovalbumin
por: Larsen, Søren T, et al.
Publicado: (2009)

Novel amide-functionalized chloramphenicol base bifunctional organocatalysts for enantioselective alcoholysis of meso-cyclic anhydrides
por: Xu, Lingjun, et al.
Publicado: (2018)

SARS-CoV-2 spike and ACE2 entanglement-like binding
por: Pregnolato, Massimo, et al.
Publicado: (2023)

Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection
por: Luan, Junwen, et al.
Publicado: (2020)

Phenothiazines Inhibit SARS-CoV-2 Entry through Targeting Spike Protein
por: Liang, Taizhen, et al.
Publicado: (2023)

The inhibitory effect of a coronavirus spike protein fragment with ACE2
por: Peter, Emanuel K., et al.
Publicado: (2021)

Structures of the Omicron Spike trimer with ACE2 and an anti-Omicron antibody
por: Yin, Wanchao, et al.
Publicado: (2022)

Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism
por: Badraoui, Riadh, et al.
Publicado: (2021)

SARS-CoV-2 Spike mutations modify the interaction between virus Spike and human ACE2 receptors
por: Mishra, Pushpendra Mani, et al.
Publicado: (2022)

Thiol drugs decrease SARS-CoV-2 lung injury in vivo and disrupt SARS-CoV-2 spike complex binding to ACE2 in vitro
por: Khanna, Kritika, et al.
Publicado: (2021)

α-Costic anhydride
por: Tebbaa, Mohamed, et al.
Publicado: (2010)

Study of the regulatory elements of the Ovalbumin gene promoter using CRISPR technology in chicken cells
por: Yousefi Taemeh, Sara, et al.
Publicado: (2023)

Molecular simulation of SARS-CoV-2 spike protein binding to pangolin ACE2 or human ACE2 natural variants reveals altered susceptibility to infection
por: Wang, Jingfang, et al.
Publicado: (2020)

Poly(ester-anhydrides) Derived from Esters of Hydroxy Acid and Cyclic Anhydrides
por: Arun, Yuvaraj, et al.
Publicado: (2022)

SARS-CoV-2 spike engagement of ACE2 primes S2′ site cleavage and fusion initiation
por: Yu, Shi, et al.
Publicado: (2021)

Comparative Structural Study of Three Tetrahalophthalic Anhydrides: Recognition of X···O(anhydride) Halogen Bond and πh···O(anhydride) Interaction
por: Baykov, Sergey V., et al.
Publicado: (2021)

Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2
por: Chan, Kui K., et al.
Publicado: (2020)

The sequence of human ACE2 is suboptimal for binding the S spike protein of SARS coronavirus 2
por: Procko, Erik
Publicado: (2020)

Revealing the Mechanism of SARS-CoV-2 Spike Protein Binding With ACE2
Publicado: (2020)

SARS-CoV-2 electrochemical immunosensor based on the spike-ACE2 complex
por: Vásquez, Viviana, et al.
Publicado: (2022)

Mechanism and evolution of human ACE2 binding by SARS-CoV-2 spike
por: Wrobel, Antoni G.
Publicado: (2023)

Design and Identification of Inhibitors for the Spike-ACE2 Target of SARS-CoV-2
por: Bastos, Ruan S., et al.
Publicado: (2023)

Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein
por: Calcagnile, Matteo, et al.
Publicado: (2021)

Modeling SARS-CoV-2 spike/ACE2 protein–protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context
por: Tragni, Vincenzo, et al.
Publicado: (2022)

Biophysical properties of the isolated spike protein binding helix of human ACE2
por: Das, Anirban, et al.
Publicado: (2021)

A peptide array pipeline for the development of Spike-ACE2 interaction inhibitors
por: Chopra, Anand, et al.
Publicado: (2022)

Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor
por: Zhao, Peng, et al.
Publicado: (2020)

Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor
por: Zhao, Peng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e7mmruhr18v9kj0c2bn84511dk